Philippe Grenier
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoparticle-Based Drug Delivery 8
-
- Advanced Drug Delivery Systems 3
- Co-authors
- Nicolas Bertrand (10 shared papers)Eliana Martins Lima (3 shared papers)Omid Cameron Farokhzad (1 shared paper)Morteza Mahmoudi (1 shared paper)Róbert Langer (1 shared paper)Rohit Karnik (1 shared paper)Eric Andrew Appel (1 shared paper)Jong‐Min Lim (1 shared paper)
In The Last Decade
Philippe Grenier
17 papers receiving 988 citations
Philippe Grenier's Hit Papers
Peers
Comparison fields: 5 of 103
- Biomaterials 480
- Pharmaceutical Science 111
- Surfaces, Coatings and Films 91
- Biomedical Engineering 296
- Molecular Biology 413
Countries citing papers authored by Philippe Grenier
This map shows the geographic impact of Philippe Grenier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Grenier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Grenier more than expected).
Fields of papers citing papers by Philippe Grenier
This network shows the impact of papers produced by Philippe Grenier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Grenier. The network helps show where Philippe Grenier may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Grenier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics Hit paper breakdown → | 2017 | 615 |
| 2 | 2018 | 108 | |
| 3 | 1987 | 106 | |
| 4 | 2018 | 49 | |
| 5 | 2022 | 32 | |
| 6 | 2021 | 17 | |
| 7 | 2020 | 14 | |
| 8 | 2024 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 1991 | 11 | |
| 11 | 2023 | 8 | |
| 12 | 1994 | 6 | |
| 13 | [Sternal locations of Hodgkins disease. A report on two cases (author's transl)]. | 1980 | 4 |
| 14 | [Colonic tubular adenoma following ureterosigmoidostomy: CT features]. | 1999 | 1 |
| 15 | 2025 | 1 | |
| 16 | 1999 | 1 | |
| 17 | 1995 | 1 |
About Philippe Grenier
Philippe Grenier is a scholar working on Biomaterials, Pharmaceutical Science, Immunology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 17 papers that have together received 1000 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (3 papers), Complement system in diseases (3 papers), Advanced Drug Delivery Systems (3 papers), Inhalation and Respiratory Drug Delivery (2 papers), Immunotherapy and Immune Responses (2 papers), Horticultural and Viticultural Research (2 papers) and Fermentation and Sensory Analysis (2 papers). The work is most often cited by research in Biomaterials (480 citations), Pharmaceutical Science (111 citations), Surfaces, Coatings and Films (91 citations), Biomedical Engineering (296 citations) and Molecular Biology (413 citations). Philippe Grenier has collaborated with scholars based in Canada, France and Brazil. Frequent co-authors include Nicolas Bertrand, Eliana Martins Lima, Omid Cameron Farokhzad, Morteza Mahmoudi, Róbert Langer, Rohit Karnik, Eric Andrew Appel, Jong‐Min Lim, Flavio Dormont and Jean-Marie Sablayrolles. Their work appears in journals such as Journal of Controlled Release, Nature Communications, Pharmaceutics, Journal of Food Science and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.